-
April 16: The Week in Cancer NewsStudies presented at the AACR Annual Meeting 2021 shed light on treatment of a variety of cancers, and articles discuss the risks of COVID-19 for people who have been vaccinated but are immunocompromised.
by Kate Yandell
-
Building COVID-19 Vaccine ConfidenceExperts discussed how the cancer community can share accurate information and increase confidence in COVID-19 vaccines, both among people with cancer and the general population.
by Kevin McLaughlin
-
Chemobrain: It’s Not Your ImaginationScientists discussed the mechanisms of chemotherapy-related cognitive impairment at a session dedicated to symptom science at the AACR Annual Meeting 2021.
by Marci A. Landsmann
-
Coverage of the AACR Annual Meeting 2021This year's AACR Annual Meeting features the latest advances in basic, translational and clinical cancer research. The more than 13,000 attendees at the virtual event represent more than 70 countries.
by Kevin McLaughlin
-
April 9: The Week in Cancer NewsA nationwide campaign encourages Americans to get their cancer screenings, and a study reports improved outcomes for patients taking oral cancer drugs when they have professional oversight.
by Kevin McLaughlin
-
Searching the Blood for Signs of Altered ImmunityThe immune systems of people with blood cancer respond differently to infection with the coronavirus than the immune systems of people without cancer or with solid tumors.
by Kate Yandell
-
April 2: The Week in Cancer NewsA study indicates that people are delaying medical care until they are eligible for Medicare, leading to missed cancers, and the Food and Drug Administration approves the first CAR-T cell therapy for multiple myeloma.
by Kate Yandell
-
March 26: The Week in Cancer NewsUnderrepresentation of members of minority groups in public genomic databases could lead to misleading test results, and a study provides new insight into how melanoma metastasizes.
by Bradley Jones
-
Immunotherapy Indications WithdrawnIn recent months, drugmakers have announced they are withdrawing indications for four immune checkpoint inhibitors in consultation with the Food and Drug Administration. What does this mean for patients who are taking these drugs?
by Anna Goshua
-
March 19: The Week in Cancer NewsA study indicates breast cancer centers often recommend earlier and more frequent screening than national guidelines, and experts ponder COVID-19 vaccines' role is quelling the evolution of concerning viral variants in people with weakened immune systems.
by Marci A. Landsmann
Scientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.
by Marci A. Landsmann
Tissue and Liquid Biopsy for Targeted TherapyTailored treatments led to better outcomes than standard of care when biomarker results from liquid biopsy and tumor tissue aligned.
by Eric Fitzsimmons
Cancer Vaccines Show Promise in Early TrialsWhile mRNA vaccines offer a personalized approach to triggering an immune response, peptide vaccines could be a one-size-fits-all treatment. Researchers are exploring both options.
by Thomas Celona
Declining Breast Cancer Mortality in Younger WomenU.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
